drug
calaspargase pegol
Marketedupdated 6mo agoby Servier Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying calaspargase pegol
- phase2Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
- phase1Venetoclax Basket Trial for High Risk Hematologic Malignancies
- phase1CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
- phase2Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- phase3SPARK-ALL: Calaspargase Pegol in Adults With ALL
- phase3Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
- phase1Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 54m ago
Found something off?
comments(0)
5-min edit window · permanent after that